Related references
Note: Only part of the references are listed.Analysis of Genomic DNA from Medieval Plague Victims Suggests Long-Term Effect of Yersinia pestis on Human Immunity Genes
Alexander Immel et al.
MOLECULAR BIOLOGY AND EVOLUTION (2021)
What we say and what we mean when we say redundancy and robustness of the chemokine system - how CCR5 challenges these concepts
Joel H. Ellwanger et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box
Joel Henrique Ellwanger et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2020)
CCR5 gene editing - Revisiting pros and cons of CCR5 absence
Joel Henrique Ellwanger et al.
INFECTION GENETICS AND EVOLUTION (2019)
Human CCR5Δ32 (rs333) polymorphism has no influence on severity and mortality of influenza A(H1N1)pdm09 infection in Brazilian patients from the post pandemic period
Aline R. Matos et al.
INFECTION GENETICS AND EVOLUTION (2019)
Evolutionary view of the AIDS process
Vladimir Zajac
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis
Jun Ni et al.
OPEN MEDICINE (2018)
Ancient DNA Investigation of a Medieval German Cemetery Confirms Long-Term Stability of CCR5-Δ32 Allele Frequencies in Central Europe
Abigail Bouwman et al.
HUMAN BIOLOGY (2017)
Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers
Ute V. Solloch et al.
HUMAN IMMUNOLOGY (2017)
The possible role of CCR5Δ32 mutation in Crimean-Congo hemorrhagic fever infection
Aydin Rustemoglu et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
CC chemokine receptor 5 32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan
Mariam Sophie et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2016)
A new look at osteomyelitis development - Focus on CCR5delta32. Study in patients from Northeast Brazil
Maria do Socorro Queiroz Alves de Souza et al.
INFECTION GENETICS AND EVOLUTION (2015)
CCR5 deficiency predisposes to fatal outcome in influenza virus infection
A. Falcon et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Immune Subversion by Mycobacterium tuberculosis through CCR5 Mediated Signaling: Involvement of IL-10
Shibali Das et al.
PLOS ONE (2014)
CCR5 Controls Immune and Metabolic Functions during Toxoplasma gondii Infection
Giuliano Bonfa et al.
PLOS ONE (2014)
Host genetic risk factors for community-acquired pneumonia
Lyubov E. Salnikova et al.
GENE (2013)
Attack Rate of Chlamydia-induced Reactive Arthritis and Effect of the CCR5-Delta-32 Mutation: A Prospective Analysis
John D. Carter et al.
JOURNAL OF RHEUMATOLOGY (2013)
Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants
Reem Berro et al.
JOURNAL OF VIROLOGY (2013)
Effect of the chemokine receptor CCR5 in the development of American cutaneous leishmaniasis in a Southern Brazilian population
Adriana Danmvolf Ribas et al.
MOLECULAR MEDICINE REPORTS (2013)
CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Francis Alonzo et al.
NATURE (2013)
Using the distribution of the CCR5-Δ32 allele in third-generation Maltese citizens to disprove the Black Death hypothesis
B. Baron et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2011)
Influence of Variations in CCL3L1 and CCR5 on Tuberculosis in a Northwestern Colombian Population
Manju Mamtani et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation
Gero Huetter et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
Historic, Demographic, and Genetic Evidence for Increased Population Frequencies of CCR5Δ32 Mutation in Croatian Island Isolates after Lethal 15th Century Epidemics
Zrinka Biloglav et al.
CROATIAN MEDICAL JOURNAL (2009)
Pros and cons of a missing chemokine receptor-Comments on Is the European spatial distribution of the HIV-1-resistant CCR5-Δ32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion? by Eric Faure and Manuela Royer-Carenzi (2008)
Andreia Escosteguy Vargas et al.
INFECTION GENETICS AND EVOLUTION (2009)
Is the European spatial distribution of the HIV-1-resistant CCR5-Δ32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?
Eric Faure et al.
INFECTION GENETICS AND EVOLUTION (2008)
HIV-1 protecting CCR5-Δ32 allele in medieval Poland
Przemyslaw Zawicki et al.
INFECTION GENETICS AND EVOLUTION (2008)
Rhinocerebral zygomycosis in an HIV-infected man during therapy with an investigational CCR5 inhibitor
Shehzad Merchant et al.
AIDS (2007)
Study of the role of CCR5 in a mouse model of intranasal challenge with Yersinia pestis
Katie L. Styer et al.
MICROBES AND INFECTION (2007)
Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis
Karen Brajao de Oliveira et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
CCR5 Delta 32 mutation, Mycoplasma pneumoniae infection, and asthma
Ildiko Ungvavi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence
Ekaterina Yurchenko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
CCL5 modulates pneumococcal immunity and carriage
R Palaniappan et al.
JOURNAL OF IMMUNOLOGY (2006)
CCR5 deficiency increases risk of symptomatic West Nile virus infection
WG Glass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The case for selection at CCR5-Δ32
PC Sabeti et al.
PLOS BIOLOGY (2005)
The geographic spread of the CCR5 Δ32 HIV-resistance allele
J Novembre et al.
PLOS BIOLOGY (2005)
Detection of the CCR5-Δ32 HIV resistance gene in Bronze Age skeletons
S Hummel et al.
GENES AND IMMUNITY (2005)
Reappraisal of the historical selective pressures for the CCR5-Δ32 mutation
SR Duncan et al.
JOURNAL OF MEDICAL GENETICS (2005)
The evolutionary history of the CCR5-Δ32 HIV-resistance mutation
AP Galvani et al.
MICROBES AND INFECTION (2005)
Allelic histories: positive selection on a HIV-resistance allele
MPH Stumpf et al.
TRENDS IN ECOLOGY & EVOLUTION (2004)
HIV and the CCR5-Δ32 resistance allele
E de Silva et al.
FEMS MICROBIOLOGY LETTERS (2004)
Evaluating plague and smallpox as historical selective pressures for the CCR5-Δ32 HIV-resistance allele
AP Galvani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
From cells to signaling cascades:: manipulation of innate immunity by Toxoplasma gondii
EY Denkers
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
More about the Viking hypothesis of origin of the Delta 32 mutation in the CCR5 gene conferring resistance to HIV-1 infection
Gerard Lucotte et al.
INFECTION GENETICS AND EVOLUTION (2003)
Frequency analysis of the CCR5Δ32 mutation in patients with brucellosis
P Skendros et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Frequencies of 32 base pair deletion of the (Δ32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis
Gerard Lucotte
INFECTION GENETICS AND EVOLUTION (2002)
Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times
G Lucotte
HUMAN IMMUNOLOGY (2001)
Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4+ T cells
NP Juffermans et al.
CLINICAL INFECTIOUS DISEASES (2001)
CCR5 provides a signal for microbial induced production of IL-12 by CD8α+ dendritic cells
J Aliberti et al.
NATURE IMMUNOLOGY (2000)
Share Paper
